LXRX logo

Lexicon Pharmaceuticals (LXRX) Non Current Assets

Annual Non Current Assets

$52.88 M
-$551.00 K-1.03%

31 December 2023

LXRX Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$52.52 M
+$5000.00+0.01%

30 September 2024

LXRX Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LXRX Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1.0%-1.1%
3 y3 years+14.8%+8.7%
5 y5 years-52.3%-35.2%

LXRX Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-1.0%+14.8%-1.7%+10.7%
5 y5 years-52.3%+14.8%-35.2%+14.0%
alltimeall time-65.3%+446.8%-67.6%+431.5%

Lexicon Pharmaceuticals Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$52.52 M(+0.0%)
June 2024
-
$52.51 M(-0.1%)
Mar 2024
-
$52.57 M(-0.6%)
Dec 2023
$176.55 M(+25.3%)
$52.88 M(-0.4%)
Sept 2023
-
$53.11 M(+0.2%)
June 2023
-
$53.00 M(-0.3%)
Mar 2023
-
$53.17 M(-0.5%)
Dec 2022
$140.87 M(+58.4%)
$53.43 M(+1.5%)
Sept 2022
-
$52.62 M(+11.0%)
June 2022
-
$47.43 M(-0.7%)
Mar 2022
-
$47.75 M(-0.5%)
Dec 2021
$88.92 M(-43.6%)
$47.99 M(-0.7%)
Sept 2021
-
$48.33 M(-0.2%)
June 2021
-
$48.41 M(+1.2%)
Mar 2021
-
$47.84 M(+3.9%)
Dec 2020
$157.72 M(-53.3%)
$46.07 M(-19.2%)
Sept 2020
-
$56.99 M(-25.4%)
June 2020
-
$76.35 M(-3.3%)
Mar 2020
-
$78.95 M(-1.3%)
Dec 2019
$337.75 M(+94.9%)
$79.96 M(-1.3%)
Sept 2019
-
$80.99 M(-26.8%)
June 2019
-
$110.68 M(-0.9%)
Mar 2019
-
$111.69 M(+0.8%)
Dec 2018
$173.32 M(-46.2%)
$110.81 M(-0.9%)
Sept 2018
-
$111.83 M(-0.8%)
June 2018
-
$112.75 M(-0.8%)
Mar 2018
-
$113.66 M(-0.8%)
Dec 2017
$322.00 M(-10.0%)
$114.54 M(-0.8%)
Sept 2017
-
$115.47 M(-0.7%)
June 2017
-
$116.33 M(-0.7%)
Mar 2017
-
$117.18 M(-0.5%)
Dec 2016
$357.87 M(-32.8%)
$117.75 M(-0.4%)
Sept 2016
-
$118.21 M(-0.4%)
June 2016
-
$118.68 M(-0.4%)
Mar 2016
-
$119.18 M(-0.3%)
Dec 2015
$532.40 M(+44.3%)
$119.56 M(+17.0%)
Sept 2015
-
$102.19 M(+0.0%)
June 2015
-
$102.17 M(-0.2%)
Mar 2015
-
$102.37 M(-0.0%)
Dec 2014
$368.99 M(+174.2%)
$102.39 M(+2.7%)
Sept 2014
-
$99.70 M(-27.4%)
June 2014
-
$137.40 M(-0.6%)
Mar 2014
-
$138.19 M(-1.0%)
Dec 2013
$134.55 M(-41.7%)
$139.61 M(-0.3%)
Sept 2013
-
$140.10 M(-0.2%)
June 2013
-
$140.32 M(-0.4%)
Mar 2013
-
$140.81 M(-0.0%)
Dec 2012
$230.94 M
$140.84 M(-0.6%)
Sept 2012
-
$141.75 M(-0.7%)
June 2012
-
$142.78 M(-0.7%)
DateAnnualQuarterly
Mar 2012
-
$143.81 M(-0.6%)
Dec 2011
$285.79 M(+33.1%)
$144.72 M(-0.7%)
Sept 2011
-
$145.72 M(-0.7%)
June 2011
-
$146.72 M(-2.3%)
Mar 2011
-
$150.22 M(-1.3%)
Dec 2010
$214.74 M(+26.6%)
$152.15 M(+12.5%)
Sept 2010
-
$135.26 M(+63.5%)
June 2010
-
$82.70 M(-5.3%)
Mar 2010
-
$87.30 M(-0.9%)
Dec 2009
$169.68 M(+55.4%)
$88.08 M(-2.1%)
Sept 2009
-
$89.97 M(-39.4%)
June 2009
-
$148.38 M(-1.2%)
Mar 2009
-
$150.24 M(-1.4%)
Dec 2008
$109.17 M(-58.8%)
$152.34 M(+0.0%)
Sept 2008
-
$152.28 M(-3.2%)
June 2008
-
$157.36 M(-3.0%)
Mar 2008
-
$162.20 M(+55.0%)
Dec 2007
$264.65 M(+209.3%)
$104.65 M(+5.9%)
Sept 2007
-
$98.79 M(-1.9%)
June 2007
-
$100.68 M(-1.9%)
Mar 2007
-
$102.59 M(-2.0%)
Dec 2006
$85.55 M(-19.3%)
$104.71 M(-2.1%)
Sept 2006
-
$106.91 M(-1.7%)
June 2006
-
$108.81 M(-1.7%)
Mar 2006
-
$110.72 M(-1.7%)
Dec 2005
$106.05 M(+7.4%)
$112.67 M(-0.8%)
Sept 2005
-
$113.59 M(-0.4%)
June 2005
-
$114.03 M(+0.6%)
Mar 2005
-
$113.34 M(+0.1%)
Dec 2004
$98.75 M(-42.4%)
$113.23 M(+1.6%)
Sept 2004
-
$111.43 M(+0.3%)
June 2004
-
$111.13 M(+0.2%)
Mar 2004
-
$110.89 M(-1.6%)
Dec 2003
$171.50 M(+28.8%)
$112.69 M(+79.6%)
Sept 2003
-
$62.74 M(-2.0%)
June 2003
-
$64.05 M(-2.9%)
Mar 2003
-
$65.98 M(-3.9%)
Dec 2002
$133.13 M(-20.0%)
$68.64 M(-7.7%)
Sept 2002
-
$74.37 M(+0.1%)
June 2002
-
$74.29 M(-4.1%)
Mar 2002
-
$77.43 M(+5.3%)
Dec 2001
$166.44 M(-19.2%)
$73.55 M(+23.8%)
Sept 2001
-
$59.39 M(+221.4%)
June 2001
-
$18.48 M(+11.7%)
Mar 2001
-
$16.55 M(+12.9%)
Dec 2000
$206.03 M(+1532.1%)
$14.66 M(+18.5%)
Sept 2000
-
$12.38 M(+25.2%)
June 2000
-
$9.88 M(-7.5%)
Mar 2000
-
$10.68 M
Dec 1999
$12.62 M
-

FAQ

  • What is Lexicon Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for Lexicon Pharmaceuticals?
  • What is Lexicon Pharmaceuticals annual non current assets year-on-year change?
  • What is Lexicon Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for Lexicon Pharmaceuticals?
  • What is Lexicon Pharmaceuticals quarterly non current assets year-on-year change?

What is Lexicon Pharmaceuticals annual long term assets?

The current annual non current assets of LXRX is $52.88 M

What is the all time high annual non current assets for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals all-time high annual long term assets is $152.34 M

What is Lexicon Pharmaceuticals annual non current assets year-on-year change?

Over the past year, LXRX annual long term assets has changed by -$551.00 K (-1.03%)

What is Lexicon Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of LXRX is $52.52 M

What is the all time high quarterly non current assets for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals all-time high quarterly long term assets is $162.20 M

What is Lexicon Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, LXRX quarterly long term assets has changed by -$590.00 K (-1.11%)